Digital Health News | pharmaphorum

News

Mulvany hits the reset button at BenevolentAI

The shape of BenevolentAI following the return of co-founder Ken Mulvany has started to crystallise and could see the company return to private hands.

News

Drug-digital dual therapy for depression starts phase 2

Gate Neurosciences' antidepressant apimostinel has started a proof-of-concept study to see if its efficacy can be boosted by a digital training tool.

News

Insulin pump firm Insulet wins $452m in trade secrets clash

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

News

Orexo exits depression DTx alliance with GAIA

Four years after buying US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal.

News

robotic arm reaching towards human arm on bright blue background

Neuralink unveils trial linking brain implant to robotic arm

Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm

News

UK digital health funding should be ringfenced, says report

IT industry group techUK has called on the government to guarantee funding for digital transformation and cyber resilience in health and social care

Mulvany hits the reset button at BenevolentAI

Drug-digital dual therapy for depression starts phase 2

Insulin pump firm Insulet wins $452m in trade secrets clash

Orexo exits depression DTx alliance with GAIA

Neuralink unveils trial linking brain implant to robotic arm

UK digital health funding should be ringfenced, says report

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks